CNS Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

CNS Pharmaceuticals

16/05/2022 14:43

* CNS Pharmaceuticals Inc  CNSP.OQ  reported a quarterly
adjusted
loss of 7 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 11 cents
per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * CNS Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 7 cents​.
    * The mean earnings estimate of analysts had risen by
about 12% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * CNS Pharmaceuticals Inc shares had fallen by 15.0% this
quarter and lost 58.7% so far this year.
    * The company reported a quarterly loss of $2.78 million.
    * Wall Street's median 12-month price target for CNS
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:42 p.m.  ​All
figures in US dollars unless otherwise stated